Announcements Trials
Browse Landscape

Status

Completed 1Available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hepatoblastoma 1Hearing Loss 1

Interventions

tempol 2balstilimab 2zolbetuximab 1zipalertinib 1venetoclax 1ulixertinib 1tisagenlecleucel 1tipifarnib 1tebentafusp 1talazoparib 1sodium thiosulfate 1selinexor 1ruxolitinib 1ribociclib 1osunprotafib 1nirogacestat 1mirdametinib 1lifileucel 1leronlimab 1idecabtagene vicleucel 1gedatolisib 1ensartinib 1dodecyl maltoside 1burosumab 1brexucabtagene autoleucel 1belantamab mafodotin 1axicabtagene ciloleucel 1asciminib 1anlotinib 1TEMPOL-H 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Available × INDUSTRY × sodium thiosulfate × Clear all
NCT04132882 2021-09-16

A Compassionate Use Program to Provide Access to Sodium Thiosulfate

TRPHARM

Available
Gastrointestinal

Hepatoblastoma, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡